檢索結果 - Peter McLaughlin
- Showing 1 - 20 results of 44
- Go to Next Page
-
1
-
2
-
3
-
4
-
5
-
6
-
7
-
8
-
9
-
10
-
11
-
12
Long-term results favor allogeneic over autologous hematopoietic stem cell transplantation in patients with refractory or recurrent indolent non-Hodgkin’s lymphoma 由 Chitra Hosing, Rima M. Saliba, Peter McLaughlin, Börje S. Andersson, Maria Alma Rodriguez, Laura M. Fayad, Fernando Cabanillas, Richard E. Champlin, Issa F. Khouri
出版 2003Artigo -
13
-
14
Myelodysplasia and acute myeloid leukemia following therapy for indolent lymphoma with fludarabine, mitoxantrone, and dexamethasone (FND) plus rituximab and interferon alpha 由 Peter McLaughlin, Elihu H. Estey, Armand B. Glassman, Jorge Romaguera, Felipe Samaniego, Ana Ayala, Kimberly Hayes, Anne Marie Maddox, H. Alejandro Preti, Fredrick B. Hagemeister
出版 2005Artigo -
15
Association of serum Rituximab (IDEC–C2B8) concentration and anti-tumor response in the treatment of recurrent low-grade or follicular non-Hodgkin’s lymphoma 由 Neil L. Berinstein, A.J. Grillo-López, Christine A. White, Isabelle Bence‐Bruckler, David G. Maloney, M. S. Czuczman, D. Green, J. Rosenberg, Peter McLaughlin, Diying Shen
出版 1998Artigo -
16
A pilot study of rituximab in patients with recurrent, classic Hodgkin disease 由 Anas Younes, Jorge Romaguera, Frederick Hagemeister, Peter McLaughlin, Maria Alma Rodriguez, Paolo Fiumara, André Goy, Sima Jeha, John T. Manning, Dan Jones, Lynne V. Abruzzo, L. Jeffrey Medeiros
出版 2003Artigo -
17
The Novel Cannabinoid CB1 Receptor Neutral Antagonist AM4113 Suppresses Food Intake and Food-Reinforced Behavior but Does not Induce Signs of Nausea in Rats 由 Kelly S. Sink, Peter McLaughlin, Jodi Wood, C. Brown, Pusheng Fan, Kiran Vemuri, Yan Pang, Teresa Olzewska, Ganesh A. Thakur, A. Makriyannis, Linda A. Parker, John D. Salamone
出版 2007Artigo -
18
Other Malignancies in Chronic Lymphocytic Leukemia/Small Lymphocytic Lymphoma 由 Apostolia M. Tsimberidou, Sijin Wen, Peter McLaughlin, Susan O’Brien, William G. Wierda, Susan Lerner, Sara S. Strom, Emil J. Freireich, L. Jeffrey Medeiros, Hagop M. Kantarjian, Michael J. Keating
出版 2008Artigo -
19
Prospective trial of targeted radioimmunotherapy with Y-90 ibritumomab tiuxetan (Zevalin) for front-line treatment of early-stage extranodal indolent ocular adnexal lymphoma 由 Bita Esmaeli, Peter McLaughlin, Barbara Pro, Felipe Samaniego, Isis Gayed, Fredrick B. Hagemeister, Jorge Romaguera, Fernando Cabanillas, Sattva S. Neelapu, R. Banay, Luis Fayad, M. Wayne Saville, Larry W. Kwak
出版 2009Artigo -
20
The Clinical Significance of Molecular Response in Indolent Follicular Lymphomas 由 Armando López‐Guillermo, Fernando Cabanillas, Peter McLaughlin, Terry Smith, Fredrick B. Hagemeister, M. A. Rodriguez, Jorge Romaguera, Anas Younes, Andreas H. Sarris, H. Alejandro Preti, William Pugh, Ming-Seng Lee
出版 1998Artigo
相關主題
Medicine
Internal medicine
Lymphoma
Gastroenterology
Chemotherapy
Surgery
Oncology
Biology
Rituximab
Immunology
Follicular lymphoma
Cyclophosphamide
Astrobiology
Physics
Refractory (planetary science)
Paleontology
Phases of clinical research
Vincristine
Biochemistry
Genetics
Mantle cell lymphoma
Pathology
Antibody
Cytarabine
Stage (stratigraphy)
Transplantation
Adverse effect
Cancer
Cancer research
Chemistry